Your browser doesn't support javascript.
loading
Endocrine therapy use and cardiovascular risk in postmenopausal breast cancer survivors.
Matthews, Anthony A; Peacock Hinton, Sharon; Stanway, Susannah; Lyon, Alexander Richard; Smeeth, Liam; Lund, Jennifer L; Bhaskaran, Krishnan.
Afiliação
  • Matthews AA; Institute of Environmental Medicine, Karolinska Institute, Stockholm, Sweden anthony.matthews@ki.se.
  • Peacock Hinton S; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
  • Stanway S; Department of Epidemiology and Population Health, London School of Hygiene & Tropical Medicine, London, UK.
  • Lyon AR; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
  • Smeeth L; Departmnet of Medicine, The Royal Marsden NHS Foundation Trust, London, UK.
  • Lund JL; National Heart and Lung Institute, Imperial College, London, UK.
  • Bhaskaran K; Royal Brompton and Harefield NHS Trust, London, UK.
Heart ; 107(16): 1327-1335, 2021 08.
Article em En | MEDLINE | ID: mdl-33177117
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tamoxifeno / Neoplasias da Mama / Doenças Cardiovasculares / Antineoplásicos Hormonais / Inibidores da Aromatase / Tromboembolia Venosa Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tamoxifeno / Neoplasias da Mama / Doenças Cardiovasculares / Antineoplásicos Hormonais / Inibidores da Aromatase / Tromboembolia Venosa Idioma: En Ano de publicação: 2021 Tipo de documento: Article